1 Article by Michael T. Lynskey
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence
BJPsych Open – March 12, 2024
Summary
A striking 77% of individuals using cannabis-based medicinal products for PTSD also experience depression, which worsens their symptoms and quality of life. However, those with depression showed greater improvement in PTSD symptoms after three months of treatment, highlighting the potential effectiveness of these products for this dual challenge.
Abstract
Background Cannabis-based medicinal products (CBMPs) are increasingly being used to treat post-traumatic stress disorder (PTSD), despite limited e...